Trials in Start-Up

MASC Trials brings together health professionals to coordinate clinical trials across our numerous melanoma and skin cancer trial sites located at hospitals and clinics throughout Australia and overseas.

The trials in start-up listed on this page are fully approved but are not yet accepting patients. Click on the trial names below for further information about these trials.

MASC Trials cannot enrol patients into a trial.

Learn how to participate in one of our clinical trials here.

Melanoma

Metastatic Melanoma

Squamous Cell Carcinoma

14.20 SOCRATES

Statins and prOgression of Coronary atheRosclerosis in melanomA patients Treated with chEckpoint inhibitorS

Chair

Professor Stephen Nicholls

Registration ID

Trial Status

Trial in Start-Up

MASC Trials Contact

05.21 BETTER

Bevacizumab and immune chEckpoint inhibitors plus hypofractionated stereotactic radioTherapy for the treatment of sympTomatic mElanoma bRain metastases

Chair

Associate Professor Tim Wang

Registration ID

TBC

Trial Status

Trial in Start-Up

MASC Trials Contact

01.21 SiroSkin

A multi-centre, randomised, double-blind, placebo-controlled trial of 1% topical Sirolimus in the chemoprevention of facial squamous cell carcinomas in solid organ transplant recipients

Chair

Professor Kiarash Khosrotehrani

Provisional Registration ID

Trial Status

Trial in Start-Up

MASC Trials Contact